Results 71 to 80 of about 4,564,900 (257)

Uso de anti-tnf na artrite reumatóide e o aparecimento de autoanticorpos e doença auto-imune. [PDF]

, 2008
Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina. Curso de Medicina.
Giassi, Karina de Souza
core  

Effects of Add‐On Icosapent Ethyl With Standard Treatment on Functional Outcomes and Inflammatory Biomarkers in Acute Ischemic Stroke: A Blinded Randomized Controlled Trial

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Ischemic stroke, a major cause of mortality and long‐term disability, results from the abrupt cessation of cerebral blood flow due to vascular occlusion or rupture. Icosapent Ethyl (EPA‐EE), approved for hypertriglyceridemia, has anti‐inflammatory and antithrombotic properties that may lessen ischemic damage.
Mitra Mahmoudi Meymand, Seyed Hossein Aghamiri, Saeed Mohmammad Soleymani, Shadiyeh Bararpoor Poshkohi, Samaneh Masoudi, Hadi Esmaily   +5 more
wiley   +1 more source

Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-alpha therapy [PDF]

, 2011
Introduction: The objective of this study was to investigate the effects of tumor necrosis factor (TNF)-alpha inhibitors on circulating T helper-type 17 (Th17) cells and Th17-related cytokines in patients with rheumatoid arthritis (RA).
Yi-Ming Chen, Der-Yuan Chen, Joung-Liang Lan, 林季千, Chen, H.H., Chia-Wei Hsieh, Chi-Chen Lin, Hsieh, C.W., Lan, J.L., Hsin-Hua Chen, Chen, D.Y., Lin, C.C., Chen, Y.M.   +12 more
core   +1 more source

Effectiveness of a supervised group exercise therapy based on the biopsychosocial model introduced simultaneously with anti-TNF therapy in anti-TNF-naive patients with active ankylosing spondylitis

, 2022
Background/aim: This study aimed to investigate the effectiveness of a supervised group exercise therapy based on the biopsychosocial model introduced simultaneously with antitumor necrosis factor (TNF) therapy in anti-TNF-naive patients with active ...
UMUT KALYONCU, ÜNAL, EDİBE, KARAKAYA KARABULUT, JALE, KİRAZ, SEDAT, SEDAT KİRAZ, KARACA, NUR BANU, NUR BANU KARACA, EDİBE ÜNAL, JALE KARAKAYA, KALYONCU, UMUT   +9 more
core   +1 more source

Anemia of Chronic Disease in Ankylosing Spondylitis: Improvement Following Anti-TNF Therapy

The Turkish Journal of Gastroenterology, 2012
Objectives: We assessed the prevalence of anemia at the initiation time of anti-tumor necrosis factor (anti-TNF) therapy and the change of hemoglobin level following anti-TNF therapy in ankylosing spondylitis (AS).
Ki-Jo KIM, Chul-Soo CHO
doaj  

Diabetes‐Associated Cognitive Impairment: Pathophysiology and Emerging Therapies

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Diabetes‐associated cognitive impairment (DACI) is a common yet underrecognized condition, manifesting along a spectrum from mild cognitive impairment to dementia. DACI encompasses patients who develop vascular dementia (VaD) or Alzheimer's disease (AD) with diabetes as a risk factor; however, in certain patients, particularly those lacking ...
Osman Corbali, Priyanka Menon, Halil I. Corbali, Ram Jagannathan, Allan I. Levey   +4 more
wiley   +1 more source

What do we miss? ASAS non-responders on anti-TNF therapy show improvement in performance-based physical function

, 2013
Objective: A prospective study was conducted in order to establish whether AS patients, who are defined as non-responders after 3 months of anti-TNF therapy, show improvement on performance-based tests of physical functioning.
Steultjens, Martijn P.M., Van der Horst-Bruinsma, Irene E., Dijkmans, Ben A.C., Van Denderen, J. Christiaan, Van Weely, Salima F.E., Nurmohamed, Michael T., Dekker, Joost   +6 more
core   +1 more source

Anti-TNF Therapy and Malignancy – A Critical Review [PDF]

, 2001
The roles of tumour necrosis factor (TNF) and anti-TNF therapy in malignancy are reviewed, including an overview of baseline risk factors for malignancy in inflammatory diseases and the incidences of malignancies observed in clinical trials of an anti ...
Karen A Dittrich, Roger B Cohen
core   +1 more source

The Development and Preclinical Assessment of Ovine Anti-TNF-α Polyclonal Antibodies for the Oral Treatment of Inflammatory Bowel Disease

, 2022
   Tumour Necrosis Factor-alpha (TNF-α) is one of the main drivers of inflammatory bowel disease (IBD). Regulating the actions of this pro-inflammatory cytokine through selective antagonism using an anti-TNF-α monoclonal antibody (mAb) provides effective
Owen Rees Griffiths (13040982)
core   +1 more source

Anti-tumor necrosis factor-α therapy may not be safe during pregnancy in women with inflammatory bowel disease: an updated meta-analysis and systematic review

BMC Pregnancy and Childbirth
Background Inflammatory Bowel Disease (IBD) affects reproductive-aged women. Active disease can lead to decreased fertility. Although the vast majority of international guidelines recommend for the continuation of anti-TNF-α during pregnancy, recent ...
Wei Huang, Xinxing Zhang, Li Zhang, Xiaosong Dai, Heping Chen, Qin Xie   +5 more
doaj   +1 more source